Most of the Hong Kong innovative drug concept stocks continued to strengthen. Among them, Huahao Zhongtian Pharmaceutical once again surged 23.55%, and surged more than 120% on the 3rd. Kang Fang Biotech rose 5.66%, and Genting Xinyao, Hengrui Pharmaceutical, Pharmaceutical Federation, China Biopharmaceuticals, Pharmaceutical Kangde, and Fosun Pharmaceutical followed suit.

Zhitongcaijing · 07/04 03:01
Most of the Hong Kong innovative drug concept stocks continued to strengthen. Among them, Huahao Zhongtian Pharmaceutical once again surged 23.55%, and surged more than 120% on the 3rd. Kang Fang Biotech rose 5.66%, and Genting Xinyao, Hengrui Pharmaceutical, Pharmaceutical Federation, China Biopharmaceuticals, Pharmaceutical Kangde, and Fosun Pharmaceutical followed suit.